FARALLON CAPITAL MANAGEMENT LLC
Q3 2026 Form 13-F

SAN FRANCISCO, CALIFORNIA
CIK 0000909661 · CRD 107322 · SEC-registered investment adviser
$23.2B Reported Value Total

FARALLON CAPITAL MANAGEMENT, L.L.C. reports 67 total accounts under management (AUM). There are 67 discretionary accounts valued at $52,076,899,000, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
71 funds · $65.4B gross asset value
Hedge Fund: $65.4B
Source: Form ADV filed 2026-09-23
Reported value
$23.2B
Quarter over quarter
—
Holdings
—
Top-10 concentration
—

Filing Structure

Reports holdings for

  • Farallon Capital Europe LLP · File #028-11719 · Q1 2014 – Q4 2024
  • Farallon Capital Europe LLP (not a 13F filer in our records) · Q3 2021 – Q3 2021 · declared by one filing
  • Farallon Capital Europe (not a 13F filer in our records) · Q1 2021 – Q2 2021 · declared by one filing
  • FARALLON PARTNERS L L C/CA (not a 13F filer in our records) · File #028-06372 · Q2 2013 – Q4 2013

Key People

Form ADV owners & control persons
Andrew James Mclean Spokes
LIMITED PARTNER
Richard Pierre Bollini II
MANAGING MEMBER
Colby Trexler Clark
MANAGING MEMBER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 16, 2026
Form 13F-HR
Reported value $23.2B
Positions 110
Change in reported value +0.7%
New positions 48
Exited positions 23
Position turnover 53.4%
Top-10 concentration 60.6%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
110 $23.2B
Q2 2026 13F
Filed Aug 14, 2026
85 $23.0B
Q1 2026 13F
Filed May 15, 2026
170 $20.5B
Q4 2025 13F
Filed Feb 17, 2026
150 $24.2B
Q3 2025 13F
Filed Nov 14, 2025
139 $24.4B
Q2 2025 13F
Filed Aug 14, 2025
142 $23.8B
Q1 2025 13F
Filed May 15, 2025
144 $20.9B
Q4 2024 13F
Filed Feb 14, 2025
145 $22.8B
Q3 2024 13F
Filed Nov 14, 2024
158 $22.8B
Q2 2024 13F
Filed Aug 14, 2024
159 $23.3B
Q1 2024 13F
Filed May 15, 2024
168 $23.6B
Q4 2023 13F
Filed Feb 14, 2024
148 $21.9B
Q3 2023 13F
Filed Nov 14, 2023
153 $61.0B
Q2 2023 13F
Filed Aug 14, 2023
158 $19.9B
Q1 2023 13F
Filed May 15, 2023
177 $33.5B
Q4 2022 13F
Filed Feb 14, 2023
226 $16.9B
Q3 2022 13F
Filed Nov 14, 2022
288 $18.2B
Q2 2022 13F
Filed Aug 15, 2022
297 $18.4B
Q1 2022 13F
Filed May 16, 2022
305 $20.7B
Q4 2021 13F
Filed Feb 14, 2022
292 $20.0B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 SPY P STATE STR SPDR S&P 500 ETF T $4.0B 17.15%
2 RVMD REVOLUTION MEDICINES INC $2.8B 11.87%
3 WBD WARNER BROS DISCOVERY INC $1.5B 6.58%
4 NTRA NATERA INC $1.1B 4.63%
5 BBIO BRIDGEBIO PHARMA INC $937.5M 4.04%
6 PTGX PROTAGONIST THERAPEUTICS INC $907.0M 3.91%
7 EXEL EXELIXIS INC $858.3M 3.7%
8 ROIV ROIVANT SCIENCES LTD $795.2M 3.43%
9 ROKU ROKU INC $633.5M 2.73%
10 AMZN AMAZON COM INC $590.1M 2.54%
11 GRAL GRAIL INC $570.2M 2.46%
12 BSX BOSTON SCIENTIFIC CORP $492.7M 2.12%
13 AVGO BROADCOM INC $490.2M 2.11%
14 CRH CRH PLC $442.2M 1.91%
15 KVUE KENVUE INC $441.8M 1.9%
16 TWST TWIST BIOSCIENCE CORP $412.8M 1.78%
17 UNH UNITEDHEALTH GROUP INC $384.9M 1.66%
18 MSFT MICROSOFT CORP $376.2M 1.62%
19 SNPS SYNOPSYS INC $373.1M 1.61%
20 KKR KKR & CO INC $354.2M 1.53%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings